Evidence map›Paper›PMID 40458710›Full record

ArticleFrontiers in microbiology2025

Disease spectrum of patients with hospital-acquired multidrug-resistant organism infections in the intensive care unit: a retrospective study.

Xiaowu Wang, Yan Liu, Yunyun Ding, Mei Li, Yong Gao, Tuantuan Li

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Prevalence and antimicrobial resistance ofFrontiers in microbiology · 2026
    Article
  5. Epidemiological and Antimicrobial Resistance Trends ofInfection and drug resistance · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaowu Wang *Department of Clinical Laboratory, The Second People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.
Yan Liu *Department of Clinical Laboratory, The Second People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.
Yunyun Ding *Department of Clinical Laboratory, The Second People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.
Mei LiDepartment of Clinical Laboratory, The Second People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.
Yong GaoDepartment of Clinical Laboratory, The Second People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.
Tuantuan LiDepartment of Clinical Laboratory, The Second People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To understand the infection status and disease spectrum distribution of patients with hospital-acquired Multidrug-resistant Organism (MDRO) Infections in an intensive care unit (ICU) before, during, and after the Methods: Data from the Second People's Hospital of Fuyang City's ICU was analyzed from three periods: pre- Results: The incidence density of hospital-acquired MDRO infections showed significant variation over the six-year period, with the highest density in the post- Conclusion: Our data show the mortality rate of hospital-acquired MDRO infections decreased during

Indexed as

Coronavirus Disease 2019disease spectrumhospital-acquired infectionintensive care unitmultidrug-resistant organism

Identifiers

PMID40458710
PMCPMC12127312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.